董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Raluca Dinu Director 51 未披露 1020.72 2025-11-12
Raanan I. Horowitz Director 64 未披露 未持股 2025-11-12
Karen Rogge Director 71 未披露 未持股 2025-11-12
Adrian Zuckerman Director 67 未披露 未持股 2025-11-12
Darius Moshfeghi Director 55 未披露 未持股 2025-11-12
Avi S. Katz Chairman of the Board and Chief Executive Officer 67 未披露 1020.72 2025-11-12

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Christine Marshall Chief Financial Officer 54 未披露 未持股 2025-11-12
Avi S. Katz Chairman of the Board and Chief Executive Officer 67 未披露 1020.72 2025-11-12

董事简历

中英对照 |  中文 |  英文
Raluca Dinu

Raluca Dinu自2024年3月起担任首席执行官、总裁、秘书,并担任QT Imaging Holdings,Inc.(OTCQB:QTIH)的董事,自2021年2月由她和Katz博士以GIG5的身份创立以来。Dinu博士在TMT行业的国际高管岗位上工作了大约21年,曾为私营初创企业、中型公司和大型企业工作。在这些角色中,Dinu博士在启动和加速实体、建立团队、大规模筹资、发展关键联盟和技术伙伴关系、并购活动、业务发展、财务管理、全球运营以及销售和营销方面发挥了重要作用。Katz和Dinu还共同创立了GigInternational1,Inc.,这是一家私人对公共股权(PPE)公司,其成立的目的是收购TMT、A & D、移动和半导体行业的一家公司,尤其侧重于欧洲、中东和非洲市场。GigInternational1于2021年5月完成首次公开募股,Dinu博士从GigInternational1成立之初就担任董事,并于2021年3月开始担任GigInternational1的首席执行官、总裁和秘书。2022年11月,GigInternational1决定对公司进行清算解散而不是进行企业合并,并于2022年12月,GigInternational1在清算其信托账户后从纳斯达克退市。Dinu博士还持有GigManagement,LLC 50%的会员权益,自GigManagement,LLC成立以来一直担任管理成员。2017年4月至2019年5月,Dinu博士担任IDT(纳斯达克:IDTI)副总裁兼Optical Interconnects Division总经理。PHE还拥有Harvard商学院的公司董事证书,这是在2021年完成了审计委员会和薪酬委员会的认证并在2022年使公司董事会更加有效之后。Dinu博士与Gigcapital8 Corp.董事会主席Katz博士结婚。


Raluca Dinu serves as one of directors and co founded Company with Dr. Avi S. Katz, who is Chief Executive Officer and Chairman, of the Board of Directors since May 2024. Dr. Dinu has spent approximately 21 years in international executive positions within the TMT indtry working for privately held start ups, middle cap companies and large enterprises. She has also served as a member of the board of directors of BigBear.ai Holdings, Inc. since its inception in December 2020 as GIG4 until March 2024, and prior to the December 2021 biness combination, was also the President, Chief Executive Officer and Secretary of GIG4 since its inception in December 2020. From February 2014 to September 2017, Dr. Dinu was a member of the board of directors of Brazil Photonics, in Campinas, Brazil, a joint venture that GigPeak established with the Centro de Pesquisa e Desenvolvimento em Telecomunicaes (CPqD). From 2001 to 2008, Dr. Dinu was Vice President of Engineering at Lumera (Nasdaq: LMRA). Lumera was acquired by GigPeak in 2008, and Dr. Dinu joined GigPeak at that time. Dr. Dinu holds a B.Sc. in Physics and Ph.D. in Solid State Condensed Matter Physics from the University of Bucharest, and an Executive M.B.A. from Stanford University. She also has a Corporate Director certificate from Harvard Biness School, after completing the certification for Audit Committees and Compensation Committees in 2021 and Making Corporate Boards More Effective in 2022.
Raluca Dinu自2024年3月起担任首席执行官、总裁、秘书,并担任QT Imaging Holdings,Inc.(OTCQB:QTIH)的董事,自2021年2月由她和Katz博士以GIG5的身份创立以来。Dinu博士在TMT行业的国际高管岗位上工作了大约21年,曾为私营初创企业、中型公司和大型企业工作。在这些角色中,Dinu博士在启动和加速实体、建立团队、大规模筹资、发展关键联盟和技术伙伴关系、并购活动、业务发展、财务管理、全球运营以及销售和营销方面发挥了重要作用。Katz和Dinu还共同创立了GigInternational1,Inc.,这是一家私人对公共股权(PPE)公司,其成立的目的是收购TMT、A & D、移动和半导体行业的一家公司,尤其侧重于欧洲、中东和非洲市场。GigInternational1于2021年5月完成首次公开募股,Dinu博士从GigInternational1成立之初就担任董事,并于2021年3月开始担任GigInternational1的首席执行官、总裁和秘书。2022年11月,GigInternational1决定对公司进行清算解散而不是进行企业合并,并于2022年12月,GigInternational1在清算其信托账户后从纳斯达克退市。Dinu博士还持有GigManagement,LLC 50%的会员权益,自GigManagement,LLC成立以来一直担任管理成员。2017年4月至2019年5月,Dinu博士担任IDT(纳斯达克:IDTI)副总裁兼Optical Interconnects Division总经理。PHE还拥有Harvard商学院的公司董事证书,这是在2021年完成了审计委员会和薪酬委员会的认证并在2022年使公司董事会更加有效之后。Dinu博士与Gigcapital8 Corp.董事会主席Katz博士结婚。
Raluca Dinu serves as one of directors and co founded Company with Dr. Avi S. Katz, who is Chief Executive Officer and Chairman, of the Board of Directors since May 2024. Dr. Dinu has spent approximately 21 years in international executive positions within the TMT indtry working for privately held start ups, middle cap companies and large enterprises. She has also served as a member of the board of directors of BigBear.ai Holdings, Inc. since its inception in December 2020 as GIG4 until March 2024, and prior to the December 2021 biness combination, was also the President, Chief Executive Officer and Secretary of GIG4 since its inception in December 2020. From February 2014 to September 2017, Dr. Dinu was a member of the board of directors of Brazil Photonics, in Campinas, Brazil, a joint venture that GigPeak established with the Centro de Pesquisa e Desenvolvimento em Telecomunicaes (CPqD). From 2001 to 2008, Dr. Dinu was Vice President of Engineering at Lumera (Nasdaq: LMRA). Lumera was acquired by GigPeak in 2008, and Dr. Dinu joined GigPeak at that time. Dr. Dinu holds a B.Sc. in Physics and Ph.D. in Solid State Condensed Matter Physics from the University of Bucharest, and an Executive M.B.A. from Stanford University. She also has a Corporate Director certificate from Harvard Biness School, after completing the certification for Audit Committees and Compensation Committees in 2021 and Making Corporate Boards More Effective in 2022.
Raanan I. Horowitz

Raanan I.Horowitz于2021年3月加入董事会,担任独立董事。自2021年2月起,他还担任GIG5的董事会成员。Horowitz先生是Elbit Systems of America,LLC的总裁,首席执行官和董事会成员,这是一家为国防,国土安全,商业航空和医疗仪器市场提供高性能产品和系统解决方案的领先提供商。他于2007年被任命为这样的职务。Elbit Systems of America,LLC是Elbit SystemsLtd.公司的全资子公司,该公司是一家为各种国防和商业应用提供创新的、基于技术的系统的全球供应商,在15个国家和地区拥有18000多名员工。在被任命领导Elbit Systems of America,LLC之前,Horowitz先生从2003年到2007年担任EFW,Inc.的执行副总裁和总经理,该公司是Elbit Systems of America的子公司。在2014年和2018年,Ethisphere Institute将美国的Elbit Systems评为世界上最有道德的公司之一。此外,Horowitz先生还活跃在A&D行业,自2008年起担任航空航天工业协会理事会成员,自2015年起担任国防工业协会理事会成员,自2014年起担任国家安全业务执行官,自2018年起担任《华尔街日报》首席执行官理事会成员。此前,他曾于2009年至2018年在美国最大的志愿者健康组织之一白血病和淋巴瘤协会(白血病淋巴瘤协会)的国家董事会任职。Horowitz先生在密歇根州阿伦代尔的大谷州立大学(Grand Valley State University)的塞德曼商学院(Seidman School of Business)获得工商管理硕士学位。他还在以色列特拉维夫大学(Tel-Aviv University)获得电气工程理学硕士学位——1991年,机械工程理学学士学位——1981年。


Raanan I. Horowitz serves as one of directors. Mr. Horowitz currently serves on the Board of Trtees of the Institute for Defense Analysis, an American non profit corporation that administers three federally funded research and development centers (FFRDCs) to assist the United States government in addressing national security issues. He also serves on the board of directors of the DFW International Airport, the board of directors of Parry Labs, a digital engineering company serving the defense market, and the board of directors of GIG7 (Nasdaq:GIG). Elbit Systems of America, LLC is a wholly owned subsidiary of Elbit Systems Ltd., a global sce of innovative, technology based systems for diverse defense and commercial applications with more than 19,500 employees in 15 countries. Prior to being appointed to lead Elbit Systems of America, LLC, Mr. Horowitz served as the Executive Vice President and General Manager of EFW, Inc., a subsidiary of Elbit Systems of America, from 2003 to 2007. In 2014, 2015, 2018, 2022 and 2023, The Ethisphere Institute named Elbit Systems of America one of the "World's Most Ethical Companies." In addition, Mr. Horowitz is active in the A&D indtry, serving on the Board of Governors of the Aerospace Indtries Association since 2008, the board of directors for the National Defense Indtrial Association since 2015, as a member of Biness Executives for National Security since 2014, and as a member of the Wall Street Jnal CEO Council from 2018 until 2024. Since April 2024, Mr. Horowitz has also been a member of the board of trtees of the Institute for Defense Analysis and the board of directors of Parry Labs, LLC, an engineering services company. Previoly, he served on the National Board of Directors for one of the nation's largest volunteer health organizations, the Leukemia & Lymphoma Society, from 2009 to 2018. Mr. Horowitz earned a Master of Biness Administration degree from the Seidman School of Biness (1993) at Grand Valley State University in Allendale, Michigan. He was also awarded a Master of Science degree in Electrical Engineering (1991) and a Bachelor of Science degree in Mechanical Engineering (1981) from Tel Aviv University in Israel.
Raanan I.Horowitz于2021年3月加入董事会,担任独立董事。自2021年2月起,他还担任GIG5的董事会成员。Horowitz先生是Elbit Systems of America,LLC的总裁,首席执行官和董事会成员,这是一家为国防,国土安全,商业航空和医疗仪器市场提供高性能产品和系统解决方案的领先提供商。他于2007年被任命为这样的职务。Elbit Systems of America,LLC是Elbit SystemsLtd.公司的全资子公司,该公司是一家为各种国防和商业应用提供创新的、基于技术的系统的全球供应商,在15个国家和地区拥有18000多名员工。在被任命领导Elbit Systems of America,LLC之前,Horowitz先生从2003年到2007年担任EFW,Inc.的执行副总裁和总经理,该公司是Elbit Systems of America的子公司。在2014年和2018年,Ethisphere Institute将美国的Elbit Systems评为世界上最有道德的公司之一。此外,Horowitz先生还活跃在A&D行业,自2008年起担任航空航天工业协会理事会成员,自2015年起担任国防工业协会理事会成员,自2014年起担任国家安全业务执行官,自2018年起担任《华尔街日报》首席执行官理事会成员。此前,他曾于2009年至2018年在美国最大的志愿者健康组织之一白血病和淋巴瘤协会(白血病淋巴瘤协会)的国家董事会任职。Horowitz先生在密歇根州阿伦代尔的大谷州立大学(Grand Valley State University)的塞德曼商学院(Seidman School of Business)获得工商管理硕士学位。他还在以色列特拉维夫大学(Tel-Aviv University)获得电气工程理学硕士学位——1991年,机械工程理学学士学位——1981年。
Raanan I. Horowitz serves as one of directors. Mr. Horowitz currently serves on the Board of Trtees of the Institute for Defense Analysis, an American non profit corporation that administers three federally funded research and development centers (FFRDCs) to assist the United States government in addressing national security issues. He also serves on the board of directors of the DFW International Airport, the board of directors of Parry Labs, a digital engineering company serving the defense market, and the board of directors of GIG7 (Nasdaq:GIG). Elbit Systems of America, LLC is a wholly owned subsidiary of Elbit Systems Ltd., a global sce of innovative, technology based systems for diverse defense and commercial applications with more than 19,500 employees in 15 countries. Prior to being appointed to lead Elbit Systems of America, LLC, Mr. Horowitz served as the Executive Vice President and General Manager of EFW, Inc., a subsidiary of Elbit Systems of America, from 2003 to 2007. In 2014, 2015, 2018, 2022 and 2023, The Ethisphere Institute named Elbit Systems of America one of the "World's Most Ethical Companies." In addition, Mr. Horowitz is active in the A&D indtry, serving on the Board of Governors of the Aerospace Indtries Association since 2008, the board of directors for the National Defense Indtrial Association since 2015, as a member of Biness Executives for National Security since 2014, and as a member of the Wall Street Jnal CEO Council from 2018 until 2024. Since April 2024, Mr. Horowitz has also been a member of the board of trtees of the Institute for Defense Analysis and the board of directors of Parry Labs, LLC, an engineering services company. Previoly, he served on the National Board of Directors for one of the nation's largest volunteer health organizations, the Leukemia & Lymphoma Society, from 2009 to 2018. Mr. Horowitz earned a Master of Biness Administration degree from the Seidman School of Biness (1993) at Grand Valley State University in Allendale, Michigan. He was also awarded a Master of Science degree in Electrical Engineering (1991) and a Bachelor of Science degree in Mechanical Engineering (1981) from Tel Aviv University in Israel.
Karen Rogge

Karen Rogge,她于2007年4月被任命为高级副总裁兼首席财务官。从2004年1月到2006年11月,她担任Seagate Technology的公司财务副总裁和司库。从2001年1月到2003年12月,她曾是独立顾问,为高科技公司提供业务战略和临时高管管理服务。从2000年1月到2000年7月,她担任Inktomi Corporation的互联网搜索部门副总裁和总经理。从1976年11月到2000年2月,她担任Hewlett-Packard Company的财务管理、信息技术管理和综合管理各种管理职务。她获得California State University Fresno的会计方向工商管理学士学位和Santa Clara University的工商管理硕士学位。


Karen Rogge serves as one of directors. Most recently, Ms. Rogge was a board director at Onto Innovation, a semiconductor equipment company, from 2021 to 2024. Previoly, she was a board director at GigCapital5 through the biness combination with QT Imaging from 2023 to March 2024, and Ramb, Inc., a semiconductor product and silicon IP company, from 2021 to 2023. Before that, she was a board director at Kemet Corporation, an electronic components company, acquired by Yageo, from 2018 to 2020. In addition, Ms. Rogge served on the board of directors of AeroCentury, an aircraft leasing company, from 2017 to 2018. She is president of the RYN Group LLC, a management consulting biness, which she founded in 2010. She has served as the interim vice president and chief financial officer of Applied Micro Circuits Corporation, a semiconductor company, from 2015 to 2016. Previoly, Ms. Rogge served as the senior vice president and chief financial officer of Extreme Networks, a computer network company, from 2007 to 2009. Earlier in her career, she held executive financial and operations management positions at Hewlett Packard Company and Seagate Technology. Ms. Rogge holds an MBA degree from Santa Clara University, and a B.S. degree in biness administration from California State University, Fresno. She maintains an NACD Board Leadership Fellow credential.
Karen Rogge,她于2007年4月被任命为高级副总裁兼首席财务官。从2004年1月到2006年11月,她担任Seagate Technology的公司财务副总裁和司库。从2001年1月到2003年12月,她曾是独立顾问,为高科技公司提供业务战略和临时高管管理服务。从2000年1月到2000年7月,她担任Inktomi Corporation的互联网搜索部门副总裁和总经理。从1976年11月到2000年2月,她担任Hewlett-Packard Company的财务管理、信息技术管理和综合管理各种管理职务。她获得California State University Fresno的会计方向工商管理学士学位和Santa Clara University的工商管理硕士学位。
Karen Rogge serves as one of directors. Most recently, Ms. Rogge was a board director at Onto Innovation, a semiconductor equipment company, from 2021 to 2024. Previoly, she was a board director at GigCapital5 through the biness combination with QT Imaging from 2023 to March 2024, and Ramb, Inc., a semiconductor product and silicon IP company, from 2021 to 2023. Before that, she was a board director at Kemet Corporation, an electronic components company, acquired by Yageo, from 2018 to 2020. In addition, Ms. Rogge served on the board of directors of AeroCentury, an aircraft leasing company, from 2017 to 2018. She is president of the RYN Group LLC, a management consulting biness, which she founded in 2010. She has served as the interim vice president and chief financial officer of Applied Micro Circuits Corporation, a semiconductor company, from 2015 to 2016. Previoly, Ms. Rogge served as the senior vice president and chief financial officer of Extreme Networks, a computer network company, from 2007 to 2009. Earlier in her career, she held executive financial and operations management positions at Hewlett Packard Company and Seagate Technology. Ms. Rogge holds an MBA degree from Santa Clara University, and a B.S. degree in biness administration from California State University, Fresno. She maintains an NACD Board Leadership Fellow credential.
Adrian Zuckerman

艾德里安·祖克曼大使,将在本招股说明书构成部分的注册声明生效后担任GigCapital7 Corp.董事。祖克曼大使曾于2019年至2021年担任美国驻罗马尼亚大使。在他的领导下,罗马尼亚与美国签署了为期十年的防务合作协议,提供财政、军事和战略支持与合作。他还推进并帮助构建了美国和罗马尼亚之间关于耗资80亿美元翻修切尔纳沃达核电站的政府间协议,其中包括翻修一个正在运行的反应堆和建造两个额外的核反应堆。为了帮助资助这个项目,大使与美国进出口银行(EXIM)谈判达成了一项70亿美元的融资协议。切尔纳沃达项目是美国和罗马尼亚有史以来规模最大的联合项目。他是罗马尼亚之星的获得者,大十字勋章。从2021年至今,祖克曼大使一直担任DLA Piper LLP(美国)的法律顾问,在跨国公司向东欧和世界各地的新兴市场扩张时,带着他作为律师和前政府官员的独特技能,就法律、监管和政府事务向它们提供建议。在此之前,他还是2013年至2019年Seyfath Shaw LLP的合伙人。祖克曼大使也是普渡大学克拉赫技术外交学院顾问委员会的成员。他拥有麻省理工学院的本科学位和纽约法学院的法学学位。


Adrian Zuckerman was the United States Ambassador to Romania from 2019 to 2021. Under his leadership Romania signed a ten year defense cooperation agreement with the United States that provided financial, military and strategic support and cooperation. He also advanced and helped structure an intergovernmental agreement beten the and Romania for the $8 billion refurbishment of the Cernavoda nuclear plant which included refurbishing one operating reactor and building two additional nuclear reactors. To help finance this project, the Ambassador negotiated a $7 billion financing agreement with the Export Import Bank of the United States (EXIM). The Cernavoda project was the largest ever joint project beten the United States and Romania. He was the recipient of the Star of Romania, Order of Grand Cross. Ambassador Zuckerman has worked as an Of Counsel to DLA Piper LLP () from 2021 to date, hasing his unique skills as a lawyer and former government official to advise multinational corporations on legal, regulatory and governmental affairs as they expand into emerging markets in Eastern Europe and around the world. He has served on the board of directors of GIG7 since Augt 2024 and GIG8 since October 2025. Before being named as the United States Ambassador to Romania, he was a partner at Seyfath Shaw LLP from 2013 to 2019. Ambassador Zuckerman is also a member of the advisory board of the Krach Institute for Tech Diplomacy at Purdue University. He holds an undergraduate degree from the Massachetts Institute of Technology and a law degree from the New York Law School.
艾德里安·祖克曼大使,将在本招股说明书构成部分的注册声明生效后担任GigCapital7 Corp.董事。祖克曼大使曾于2019年至2021年担任美国驻罗马尼亚大使。在他的领导下,罗马尼亚与美国签署了为期十年的防务合作协议,提供财政、军事和战略支持与合作。他还推进并帮助构建了美国和罗马尼亚之间关于耗资80亿美元翻修切尔纳沃达核电站的政府间协议,其中包括翻修一个正在运行的反应堆和建造两个额外的核反应堆。为了帮助资助这个项目,大使与美国进出口银行(EXIM)谈判达成了一项70亿美元的融资协议。切尔纳沃达项目是美国和罗马尼亚有史以来规模最大的联合项目。他是罗马尼亚之星的获得者,大十字勋章。从2021年至今,祖克曼大使一直担任DLA Piper LLP(美国)的法律顾问,在跨国公司向东欧和世界各地的新兴市场扩张时,带着他作为律师和前政府官员的独特技能,就法律、监管和政府事务向它们提供建议。在此之前,他还是2013年至2019年Seyfath Shaw LLP的合伙人。祖克曼大使也是普渡大学克拉赫技术外交学院顾问委员会的成员。他拥有麻省理工学院的本科学位和纽约法学院的法学学位。
Adrian Zuckerman was the United States Ambassador to Romania from 2019 to 2021. Under his leadership Romania signed a ten year defense cooperation agreement with the United States that provided financial, military and strategic support and cooperation. He also advanced and helped structure an intergovernmental agreement beten the and Romania for the $8 billion refurbishment of the Cernavoda nuclear plant which included refurbishing one operating reactor and building two additional nuclear reactors. To help finance this project, the Ambassador negotiated a $7 billion financing agreement with the Export Import Bank of the United States (EXIM). The Cernavoda project was the largest ever joint project beten the United States and Romania. He was the recipient of the Star of Romania, Order of Grand Cross. Ambassador Zuckerman has worked as an Of Counsel to DLA Piper LLP () from 2021 to date, hasing his unique skills as a lawyer and former government official to advise multinational corporations on legal, regulatory and governmental affairs as they expand into emerging markets in Eastern Europe and around the world. He has served on the board of directors of GIG7 since Augt 2024 and GIG8 since October 2025. Before being named as the United States Ambassador to Romania, he was a partner at Seyfath Shaw LLP from 2013 to 2019. Ambassador Zuckerman is also a member of the advisory board of the Krach Institute for Tech Diplomacy at Purdue University. He holds an undergraduate degree from the Massachetts Institute of Technology and a law degree from the New York Law School.
Darius Moshfeghi

Darius Moshfeghi教授将在本招股说明书构成部分的注册声明生效后担任GigCapital7 Corp.董事。Moshfeghi教授是斯坦福大学医学院拜尔斯眼科研究所的教授兼视网膜主任,自2002年以来,他一直在该研究所工作,并在那里建立了玻璃体视网膜研究金项目。他因推动远程医疗预防早产儿和足月儿失明的开创性工作而获得国际认可,于2005年建立了斯坦福大学早产儿视网膜病变诊断网络(SUNDROP)网络。自2017年以来,Moshfeghi博士一直领导斯坦福大学和Pediatrix之间的远程医疗ROP筛查计划(TeleROP)合作。SUNDROP和TeleROP为> 2.5%的美国新生儿重症监护病房和3.8%符合条件的婴儿提供ROP筛查覆盖率。他的创业工作围绕眼健康领域的远程医疗应用展开:2020年,他创立了Placid0并担任其董事长,直到2021年被Waldo,Inc.收购,并从2017年起担任1800 Contacts的董事会成员,直到2020年被KKR收购。Moshfeghi博士与Jochen Kumm博士合作,于2017年成立了Pr3vent,对健康新生儿的视网膜和眼部异常实施普遍的新生儿眼部筛查,目前担任董事会成员。他是眼科成像协同社区— ROP部分的创始成员,2019年至今任职,该部门与FDA合作制定新技术指南,并于2014年至2022年担任美国眼科学会远程医疗工作组成员,2009年至2011年担任ROP远程医疗工作组小组成员。他于2019年至今领导了再生元制药 BUTTERFLEYE试验指导委员会,并于2018年至2020年领导了阿柏西普用于ROP的拜耳FIREFLEYE试验摄影成像委员会。他领导着2023年至今的Akebia、2023年至今的Feliqs和2023年的Aspire Pharma的科学顾问委员会,以开展其在ROP方面的预防试验。他还于2024年至今加入了Ocular Therapeutix, Inc.独立医疗监测机构Rescue Therapy,以及Osanni Bio,Inc.数据监测委员会,并于2024年加入该委员会担任主席并继续任职。活跃于2022年至今与Affamed合作的数据监测安全委员会、2015年至2018年与爱尔康合作的数据监测安全委员会、2023年至今与Icon Clinical Research、Insite DME合作的数据监测安全委员会、2019年至2020年与诺华合作的数据监测安全委员会、2023年至今与Vanotech Chengdu合作的数据监测安全委员会。


Darius Moshfeghi serves as one of directors. Professor Moshfeghi is Professor and Chief of Retina at the Byers Eye Institute at the Stanford University School of Medicine where he has been continuoly employed since 2002, and where he established the vitreoretinal fellowship program. He is internationally recognized for his pioneering work to promote telemedicine for the prevention of blindness in premature and term infants, establishing the Stanford University Network for the Diagnosis of Retinopathy of Prematurity (SUNDROP) network in 2005. Dr. Moshfeghi has led the Telemedicine for ROP screening program (TeleROP) collaboration beten Stanford University and Pediatrix since 2017. SUNDROP and TeleROP provide ROP screening coverage for >2.5% of A neonatal intensive care units and 3.8% of eligible infants. His entrepreneurial work centers around telemedicine applications in eye health: in 2020, he founded and was Chairman of Placid0 until its acquisition by Waldo, Inc., in 2021 and served on the Board of directors of 1800 Contacts from 2017 until its acquisition by KKR in 2020. He led the steering committee for the Regeneron BUTTERFLEYE trial from 2019 to present and the photographic imaging committee for Bayer FIREFLEYE trial of aflibercept for ROP from 2018 to 2020. He leads the scientific advisory boards for Akebia from 2023 to present, Feliqs from 2023 to present, and Aspire Pharma in 2023 for their prevention trials in ROP. He also joined the Ocular Therapeutix, Inc. Independent Medical Monitor, Rescue Therapy in 2024 until present, and the Osanni Bio, Inc., Data Monitoring Committee, where he joined as Chair in 2024 and continues to serve. He is active in Data Monitoring Safety Boards working with Affamed from 2022 to present, Alcon from 2015 to 2018, Icon Clinical Research, Insite DME from 2023 to present, Novartis from 2019 to 2020, and Vanotech Chengdu from 2023 to present.
Darius Moshfeghi教授将在本招股说明书构成部分的注册声明生效后担任GigCapital7 Corp.董事。Moshfeghi教授是斯坦福大学医学院拜尔斯眼科研究所的教授兼视网膜主任,自2002年以来,他一直在该研究所工作,并在那里建立了玻璃体视网膜研究金项目。他因推动远程医疗预防早产儿和足月儿失明的开创性工作而获得国际认可,于2005年建立了斯坦福大学早产儿视网膜病变诊断网络(SUNDROP)网络。自2017年以来,Moshfeghi博士一直领导斯坦福大学和Pediatrix之间的远程医疗ROP筛查计划(TeleROP)合作。SUNDROP和TeleROP为> 2.5%的美国新生儿重症监护病房和3.8%符合条件的婴儿提供ROP筛查覆盖率。他的创业工作围绕眼健康领域的远程医疗应用展开:2020年,他创立了Placid0并担任其董事长,直到2021年被Waldo,Inc.收购,并从2017年起担任1800 Contacts的董事会成员,直到2020年被KKR收购。Moshfeghi博士与Jochen Kumm博士合作,于2017年成立了Pr3vent,对健康新生儿的视网膜和眼部异常实施普遍的新生儿眼部筛查,目前担任董事会成员。他是眼科成像协同社区— ROP部分的创始成员,2019年至今任职,该部门与FDA合作制定新技术指南,并于2014年至2022年担任美国眼科学会远程医疗工作组成员,2009年至2011年担任ROP远程医疗工作组小组成员。他于2019年至今领导了再生元制药 BUTTERFLEYE试验指导委员会,并于2018年至2020年领导了阿柏西普用于ROP的拜耳FIREFLEYE试验摄影成像委员会。他领导着2023年至今的Akebia、2023年至今的Feliqs和2023年的Aspire Pharma的科学顾问委员会,以开展其在ROP方面的预防试验。他还于2024年至今加入了Ocular Therapeutix, Inc.独立医疗监测机构Rescue Therapy,以及Osanni Bio,Inc.数据监测委员会,并于2024年加入该委员会担任主席并继续任职。活跃于2022年至今与Affamed合作的数据监测安全委员会、2015年至2018年与爱尔康合作的数据监测安全委员会、2023年至今与Icon Clinical Research、Insite DME合作的数据监测安全委员会、2019年至2020年与诺华合作的数据监测安全委员会、2023年至今与Vanotech Chengdu合作的数据监测安全委员会。
Darius Moshfeghi serves as one of directors. Professor Moshfeghi is Professor and Chief of Retina at the Byers Eye Institute at the Stanford University School of Medicine where he has been continuoly employed since 2002, and where he established the vitreoretinal fellowship program. He is internationally recognized for his pioneering work to promote telemedicine for the prevention of blindness in premature and term infants, establishing the Stanford University Network for the Diagnosis of Retinopathy of Prematurity (SUNDROP) network in 2005. Dr. Moshfeghi has led the Telemedicine for ROP screening program (TeleROP) collaboration beten Stanford University and Pediatrix since 2017. SUNDROP and TeleROP provide ROP screening coverage for >2.5% of A neonatal intensive care units and 3.8% of eligible infants. His entrepreneurial work centers around telemedicine applications in eye health: in 2020, he founded and was Chairman of Placid0 until its acquisition by Waldo, Inc., in 2021 and served on the Board of directors of 1800 Contacts from 2017 until its acquisition by KKR in 2020. He led the steering committee for the Regeneron BUTTERFLEYE trial from 2019 to present and the photographic imaging committee for Bayer FIREFLEYE trial of aflibercept for ROP from 2018 to 2020. He leads the scientific advisory boards for Akebia from 2023 to present, Feliqs from 2023 to present, and Aspire Pharma in 2023 for their prevention trials in ROP. He also joined the Ocular Therapeutix, Inc. Independent Medical Monitor, Rescue Therapy in 2024 until present, and the Osanni Bio, Inc., Data Monitoring Committee, where he joined as Chair in 2024 and continues to serve. He is active in Data Monitoring Safety Boards working with Affamed from 2022 to present, Alcon from 2015 to 2018, Icon Clinical Research, Insite DME from 2023 to present, Novartis from 2019 to 2020, and Vanotech Chengdu from 2023 to present.
Avi S. Katz

Avi S. Katz与Raluca Dinu博士共同创立了公司,他也是GigCapital7的董事。Katz博士自2024年5月GigCapital7成立以来一直担任首席执行官和董事会主席。Katz博士持有赞助商50%的间接会员权益。Katz博士还持有赞助商的管理公司GigManagement,LLC 50%的会员权益,自该管理公司成立以来一直担任该管理公司的管理成员。Katz博士以这一身份指导了许多重组和再融资,包括在2021年6月以约2.25亿美元的现金加股票交易从黑石手中收购了mGAGE。在此之前,Katz博士曾担任GIG1的执行主席、秘书和首席执行官。2019年3月,Katz博士创立了GIG2,这是一家私募股权到公募股权(PPE)公司,成立的目的是收购TMT行业的一家公司。GIG2于2019年6月完成首次公开募股,其中以每单位10.00美元的价格出售了17,250,000个单位,每个单位包括一股GIG2普通股、一份购买一股GIG2普通股的认股权证,以及一份获得一股GIG2普通股的十分之一(1/20)的权利,产生的总收益约为1.73亿美元。2021年6月8日,GIG2完成了与UpHealth Holdings,Inc.和Cloudbreak Health,LLC各自的Biness合并,公司更名为UpHealth,Inc.并在纽约证券交易所上市,新股票代码为“UPH”,在该公司保持上市状态,直至2024年从纽约证券交易所退市并开始在OTC Pink交易,随后在OTC Expert Market上市,新股票代码为“UPHL”。Katz博士最初担任GIG2的首席执行官,直到2019年8月,Dinu博士接替他担任该职位。他是以色列海军学院1976届毕业生,1979 A海军ASW班毕业生,拥有Technion(以色列理工学院)材料学士和博士学位。


Avi S. Katz co founded Company together with Dr. Raluca Dinu, who is also a director of GigCapital7. Dr. Katz has served as the Chief Executive Officer and the Chairman of the Board since the inception of GigCapital7 in May 2024. Dr. Katz holds 50% indirect membership interest in the Sponsor. Dr. Katz also holds a 50% membership interest in GigManagement, LLC, the managing company of the Sponsor, and has served as a managing member of such managing company since its inception. In this capacity, Dr. Katz steered many restructurings and refinancings, including the acquisition of mGage from Blackstone for about $225 million in a cash and stock deal in June 2021. Prior to that time, Dr. Katz served as the Executive Chairman, Secretary, and Chief Executive Officer of GIG1. In March 2019, Dr. Katz founded GIG2, a Private to Public Equity (PPE) company formed for the purpose of acquiring a company in the TMT indtry. GIG2 completed its initial public offering in June 2019, in which it sold 17,250,000 units at a per unit price of $10.00, with each unit consisting of one share of GIG2 common stock, one warrant to purchase one share of GIG2 common stock, and one right to receive one tntieth (1/20) of one share of GIG2 common stock, generating aggregate proceeds of about $173 million. On June 8, 2021, GIG2 completed its biness combination with each of UpHealth Holdings, Inc. and Cloudbreak Health, LLC, and the company changed its name to UpHealth, Inc. and was listed on the NYSE under the new ticker symbol "UPH", where it remained listed until 2024 when it was delisted from the NYSE and commenced trading on the OTC Pink, and subsequently on the OTC Expert Market, under the new ticker symbol "UPHL." Dr. Katz initially served as the Chief Executive Officer of GIG2 until Augt 2019, when Dr. Dinu substituted for him in that position. He is a graduate of the 1976 class of the Israeli Naval Academy, graduate of the 1979 A Naval ASW class, and holds a B.Sc. and Ph.D. in Materials from the Technion (Israel Institute of Technology).
Avi S. Katz与Raluca Dinu博士共同创立了公司,他也是GigCapital7的董事。Katz博士自2024年5月GigCapital7成立以来一直担任首席执行官和董事会主席。Katz博士持有赞助商50%的间接会员权益。Katz博士还持有赞助商的管理公司GigManagement,LLC 50%的会员权益,自该管理公司成立以来一直担任该管理公司的管理成员。Katz博士以这一身份指导了许多重组和再融资,包括在2021年6月以约2.25亿美元的现金加股票交易从黑石手中收购了mGAGE。在此之前,Katz博士曾担任GIG1的执行主席、秘书和首席执行官。2019年3月,Katz博士创立了GIG2,这是一家私募股权到公募股权(PPE)公司,成立的目的是收购TMT行业的一家公司。GIG2于2019年6月完成首次公开募股,其中以每单位10.00美元的价格出售了17,250,000个单位,每个单位包括一股GIG2普通股、一份购买一股GIG2普通股的认股权证,以及一份获得一股GIG2普通股的十分之一(1/20)的权利,产生的总收益约为1.73亿美元。2021年6月8日,GIG2完成了与UpHealth Holdings,Inc.和Cloudbreak Health,LLC各自的Biness合并,公司更名为UpHealth,Inc.并在纽约证券交易所上市,新股票代码为“UPH”,在该公司保持上市状态,直至2024年从纽约证券交易所退市并开始在OTC Pink交易,随后在OTC Expert Market上市,新股票代码为“UPHL”。Katz博士最初担任GIG2的首席执行官,直到2019年8月,Dinu博士接替他担任该职位。他是以色列海军学院1976届毕业生,1979 A海军ASW班毕业生,拥有Technion(以色列理工学院)材料学士和博士学位。
Avi S. Katz co founded Company together with Dr. Raluca Dinu, who is also a director of GigCapital7. Dr. Katz has served as the Chief Executive Officer and the Chairman of the Board since the inception of GigCapital7 in May 2024. Dr. Katz holds 50% indirect membership interest in the Sponsor. Dr. Katz also holds a 50% membership interest in GigManagement, LLC, the managing company of the Sponsor, and has served as a managing member of such managing company since its inception. In this capacity, Dr. Katz steered many restructurings and refinancings, including the acquisition of mGage from Blackstone for about $225 million in a cash and stock deal in June 2021. Prior to that time, Dr. Katz served as the Executive Chairman, Secretary, and Chief Executive Officer of GIG1. In March 2019, Dr. Katz founded GIG2, a Private to Public Equity (PPE) company formed for the purpose of acquiring a company in the TMT indtry. GIG2 completed its initial public offering in June 2019, in which it sold 17,250,000 units at a per unit price of $10.00, with each unit consisting of one share of GIG2 common stock, one warrant to purchase one share of GIG2 common stock, and one right to receive one tntieth (1/20) of one share of GIG2 common stock, generating aggregate proceeds of about $173 million. On June 8, 2021, GIG2 completed its biness combination with each of UpHealth Holdings, Inc. and Cloudbreak Health, LLC, and the company changed its name to UpHealth, Inc. and was listed on the NYSE under the new ticker symbol "UPH", where it remained listed until 2024 when it was delisted from the NYSE and commenced trading on the OTC Pink, and subsequently on the OTC Expert Market, under the new ticker symbol "UPHL." Dr. Katz initially served as the Chief Executive Officer of GIG2 until Augt 2019, when Dr. Dinu substituted for him in that position. He is a graduate of the 1976 class of the Israeli Naval Academy, graduate of the 1979 A Naval ASW class, and holds a B.Sc. and Ph.D. in Materials from the Technion (Israel Institute of Technology).

高管简历

中英对照 |  中文 |  英文
Christine Marshall

Christine Marshall,2024年5月加入公司担任首席财务官。Marshall女士是一位卓有成就的财务领导者,在GAAP、SEC报告、SOX合规、财务政策和程序、流程改进、并购、债务发行和运营会计方面拥有广泛的专业知识。在她漫长的职业生涯中,马歇尔女士在建立和领导高绩效团队方面有着良好的记录。在加入公司之前,Marshall女士于2023年9月至2024年3月期间担任DeWinter Group的顾问,并以该身份担任其SaaS客户之一的临时控制人。2015年至2023年,Marshall女士担任会计部高级总监,部分时间担任Vocera Communications, Inc.的助理财务总监,该公司是一家为各种环境中的语音通信提供基于无线网络的软件解决方案的公司,该公司于2022年2月被史赛克公司收购。她的丰富经验还包括在2009年至2015年期间担任多家公司的外部报告和技术会计顾问。从2005年到2007年,Marshall女士还在Adaptec,Inc.(一家被微芯科技收购的计算机存储公司)担任外部报告经理,履行管理和技术会计职能。1993年至2004年,她还曾在全球最大的会计师事务所之一德勤担任鉴证和咨询服务高级经理。Marshall女士拥有圣克拉拉大学商业理学学士学位,是加利福尼亚州的注册会计师(非在职)。


Christine Marshall joined Company as Chief Financial Officer in May 2024. Ms. Marshall is an accomplished finance leader with extensive expertise in GAAP, SEC reporting, SOX compliance, financial policies and procedures, process enhancements, mergers and acquisitions, debt offerings and operation accounting. Ms. Marshall has a proven track record of building and leading high performing teams throughout her long career. Prior to joining company, Ms. Marshall was a consultant for the DeWinter Group from September 2023 to March 2024, and in that capacity, acted as the Interim Controller for one of their SaaS clients. Mr. Marshall has also been the chief financial officer of GIG7 since May 2024. From 2015 to 2023, Ms. Marshall was the Senior Director of Accounting, as ll as for a portion that time, the Assistant Controller at Vocera Communications, Inc., a company supplying a wireless network based software solution for voice communication in a variety of settings, which was acquired by Stryker Corporation in February 2022. Her extensive experience also includes actin as an External Reporting and Technical Accounting Consultant from 2009 until 2015 for a number of companies. From 2005 until 2007, Ms. Marshall also performed management and technical accounting functions in her role as External Reporting Manager at Adaptec, Inc., a computer storage company acquired by Microchip Technology. She was also previoly a Senior Manager of Assurance and Advisory Services at Deloitte, one of the largest global accounting firms, from 1993 until 2004. Ms. Marshall holds a Bachelor of Science in Commerce from Santa Clara University and is a Certified Public Accountant (inactive) with the State of California.
Christine Marshall,2024年5月加入公司担任首席财务官。Marshall女士是一位卓有成就的财务领导者,在GAAP、SEC报告、SOX合规、财务政策和程序、流程改进、并购、债务发行和运营会计方面拥有广泛的专业知识。在她漫长的职业生涯中,马歇尔女士在建立和领导高绩效团队方面有着良好的记录。在加入公司之前,Marshall女士于2023年9月至2024年3月期间担任DeWinter Group的顾问,并以该身份担任其SaaS客户之一的临时控制人。2015年至2023年,Marshall女士担任会计部高级总监,部分时间担任Vocera Communications, Inc.的助理财务总监,该公司是一家为各种环境中的语音通信提供基于无线网络的软件解决方案的公司,该公司于2022年2月被史赛克公司收购。她的丰富经验还包括在2009年至2015年期间担任多家公司的外部报告和技术会计顾问。从2005年到2007年,Marshall女士还在Adaptec,Inc.(一家被微芯科技收购的计算机存储公司)担任外部报告经理,履行管理和技术会计职能。1993年至2004年,她还曾在全球最大的会计师事务所之一德勤担任鉴证和咨询服务高级经理。Marshall女士拥有圣克拉拉大学商业理学学士学位,是加利福尼亚州的注册会计师(非在职)。
Christine Marshall joined Company as Chief Financial Officer in May 2024. Ms. Marshall is an accomplished finance leader with extensive expertise in GAAP, SEC reporting, SOX compliance, financial policies and procedures, process enhancements, mergers and acquisitions, debt offerings and operation accounting. Ms. Marshall has a proven track record of building and leading high performing teams throughout her long career. Prior to joining company, Ms. Marshall was a consultant for the DeWinter Group from September 2023 to March 2024, and in that capacity, acted as the Interim Controller for one of their SaaS clients. Mr. Marshall has also been the chief financial officer of GIG7 since May 2024. From 2015 to 2023, Ms. Marshall was the Senior Director of Accounting, as ll as for a portion that time, the Assistant Controller at Vocera Communications, Inc., a company supplying a wireless network based software solution for voice communication in a variety of settings, which was acquired by Stryker Corporation in February 2022. Her extensive experience also includes actin as an External Reporting and Technical Accounting Consultant from 2009 until 2015 for a number of companies. From 2005 until 2007, Ms. Marshall also performed management and technical accounting functions in her role as External Reporting Manager at Adaptec, Inc., a computer storage company acquired by Microchip Technology. She was also previoly a Senior Manager of Assurance and Advisory Services at Deloitte, one of the largest global accounting firms, from 1993 until 2004. Ms. Marshall holds a Bachelor of Science in Commerce from Santa Clara University and is a Certified Public Accountant (inactive) with the State of California.
Avi S. Katz

Avi S. Katz与Raluca Dinu博士共同创立了公司,他也是GigCapital7的董事。Katz博士自2024年5月GigCapital7成立以来一直担任首席执行官和董事会主席。Katz博士持有赞助商50%的间接会员权益。Katz博士还持有赞助商的管理公司GigManagement,LLC 50%的会员权益,自该管理公司成立以来一直担任该管理公司的管理成员。Katz博士以这一身份指导了许多重组和再融资,包括在2021年6月以约2.25亿美元的现金加股票交易从黑石手中收购了mGAGE。在此之前,Katz博士曾担任GIG1的执行主席、秘书和首席执行官。2019年3月,Katz博士创立了GIG2,这是一家私募股权到公募股权(PPE)公司,成立的目的是收购TMT行业的一家公司。GIG2于2019年6月完成首次公开募股,其中以每单位10.00美元的价格出售了17,250,000个单位,每个单位包括一股GIG2普通股、一份购买一股GIG2普通股的认股权证,以及一份获得一股GIG2普通股的十分之一(1/20)的权利,产生的总收益约为1.73亿美元。2021年6月8日,GIG2完成了与UpHealth Holdings,Inc.和Cloudbreak Health,LLC各自的Biness合并,公司更名为UpHealth,Inc.并在纽约证券交易所上市,新股票代码为“UPH”,在该公司保持上市状态,直至2024年从纽约证券交易所退市并开始在OTC Pink交易,随后在OTC Expert Market上市,新股票代码为“UPHL”。Katz博士最初担任GIG2的首席执行官,直到2019年8月,Dinu博士接替他担任该职位。他是以色列海军学院1976届毕业生,1979 A海军ASW班毕业生,拥有Technion(以色列理工学院)材料学士和博士学位。


Avi S. Katz co founded Company together with Dr. Raluca Dinu, who is also a director of GigCapital7. Dr. Katz has served as the Chief Executive Officer and the Chairman of the Board since the inception of GigCapital7 in May 2024. Dr. Katz holds 50% indirect membership interest in the Sponsor. Dr. Katz also holds a 50% membership interest in GigManagement, LLC, the managing company of the Sponsor, and has served as a managing member of such managing company since its inception. In this capacity, Dr. Katz steered many restructurings and refinancings, including the acquisition of mGage from Blackstone for about $225 million in a cash and stock deal in June 2021. Prior to that time, Dr. Katz served as the Executive Chairman, Secretary, and Chief Executive Officer of GIG1. In March 2019, Dr. Katz founded GIG2, a Private to Public Equity (PPE) company formed for the purpose of acquiring a company in the TMT indtry. GIG2 completed its initial public offering in June 2019, in which it sold 17,250,000 units at a per unit price of $10.00, with each unit consisting of one share of GIG2 common stock, one warrant to purchase one share of GIG2 common stock, and one right to receive one tntieth (1/20) of one share of GIG2 common stock, generating aggregate proceeds of about $173 million. On June 8, 2021, GIG2 completed its biness combination with each of UpHealth Holdings, Inc. and Cloudbreak Health, LLC, and the company changed its name to UpHealth, Inc. and was listed on the NYSE under the new ticker symbol "UPH", where it remained listed until 2024 when it was delisted from the NYSE and commenced trading on the OTC Pink, and subsequently on the OTC Expert Market, under the new ticker symbol "UPHL." Dr. Katz initially served as the Chief Executive Officer of GIG2 until Augt 2019, when Dr. Dinu substituted for him in that position. He is a graduate of the 1976 class of the Israeli Naval Academy, graduate of the 1979 A Naval ASW class, and holds a B.Sc. and Ph.D. in Materials from the Technion (Israel Institute of Technology).
Avi S. Katz与Raluca Dinu博士共同创立了公司,他也是GigCapital7的董事。Katz博士自2024年5月GigCapital7成立以来一直担任首席执行官和董事会主席。Katz博士持有赞助商50%的间接会员权益。Katz博士还持有赞助商的管理公司GigManagement,LLC 50%的会员权益,自该管理公司成立以来一直担任该管理公司的管理成员。Katz博士以这一身份指导了许多重组和再融资,包括在2021年6月以约2.25亿美元的现金加股票交易从黑石手中收购了mGAGE。在此之前,Katz博士曾担任GIG1的执行主席、秘书和首席执行官。2019年3月,Katz博士创立了GIG2,这是一家私募股权到公募股权(PPE)公司,成立的目的是收购TMT行业的一家公司。GIG2于2019年6月完成首次公开募股,其中以每单位10.00美元的价格出售了17,250,000个单位,每个单位包括一股GIG2普通股、一份购买一股GIG2普通股的认股权证,以及一份获得一股GIG2普通股的十分之一(1/20)的权利,产生的总收益约为1.73亿美元。2021年6月8日,GIG2完成了与UpHealth Holdings,Inc.和Cloudbreak Health,LLC各自的Biness合并,公司更名为UpHealth,Inc.并在纽约证券交易所上市,新股票代码为“UPH”,在该公司保持上市状态,直至2024年从纽约证券交易所退市并开始在OTC Pink交易,随后在OTC Expert Market上市,新股票代码为“UPHL”。Katz博士最初担任GIG2的首席执行官,直到2019年8月,Dinu博士接替他担任该职位。他是以色列海军学院1976届毕业生,1979 A海军ASW班毕业生,拥有Technion(以色列理工学院)材料学士和博士学位。
Avi S. Katz co founded Company together with Dr. Raluca Dinu, who is also a director of GigCapital7. Dr. Katz has served as the Chief Executive Officer and the Chairman of the Board since the inception of GigCapital7 in May 2024. Dr. Katz holds 50% indirect membership interest in the Sponsor. Dr. Katz also holds a 50% membership interest in GigManagement, LLC, the managing company of the Sponsor, and has served as a managing member of such managing company since its inception. In this capacity, Dr. Katz steered many restructurings and refinancings, including the acquisition of mGage from Blackstone for about $225 million in a cash and stock deal in June 2021. Prior to that time, Dr. Katz served as the Executive Chairman, Secretary, and Chief Executive Officer of GIG1. In March 2019, Dr. Katz founded GIG2, a Private to Public Equity (PPE) company formed for the purpose of acquiring a company in the TMT indtry. GIG2 completed its initial public offering in June 2019, in which it sold 17,250,000 units at a per unit price of $10.00, with each unit consisting of one share of GIG2 common stock, one warrant to purchase one share of GIG2 common stock, and one right to receive one tntieth (1/20) of one share of GIG2 common stock, generating aggregate proceeds of about $173 million. On June 8, 2021, GIG2 completed its biness combination with each of UpHealth Holdings, Inc. and Cloudbreak Health, LLC, and the company changed its name to UpHealth, Inc. and was listed on the NYSE under the new ticker symbol "UPH", where it remained listed until 2024 when it was delisted from the NYSE and commenced trading on the OTC Pink, and subsequently on the OTC Expert Market, under the new ticker symbol "UPHL." Dr. Katz initially served as the Chief Executive Officer of GIG2 until Augt 2019, when Dr. Dinu substituted for him in that position. He is a graduate of the 1976 class of the Israeli Naval Academy, graduate of the 1979 A Naval ASW class, and holds a B.Sc. and Ph.D. in Materials from the Technion (Israel Institute of Technology).